Annual Retained Earnings
$15.57 B
+$3.97 B+34.20%
31 December 2023
Summary:
Novo Nordisk A/S annual retained earnings is currently $15.57 billion, with the most recent change of +$3.97 billion (+34.20%) on 31 December 2023. During the last 3 years, it has risen by +$5.02 billion (+47.67%). NVO annual retained earnings is now at all-time high.NVO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$18.22 B
+$2.12 B+13.20%
30 September 2024
Summary:
Novo Nordisk A/S quarterly retained earnings is currently $18.22 billion, with the most recent change of +$2.12 billion (+13.20%) on 30 September 2024. Over the past year, it has increased by +$5.23 billion (+40.27%). NVO quarterly retained earnings is now at all-time high.NVO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.2% | +40.3% |
| 3 y3 years | +47.7% | +72.0% |
| 5 y5 years | +90.3% | +131.5% |
NVO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.7% | at high | +87.2% |
| 5 y | 5 years | at high | +90.3% | at high | +131.5% |
| alltime | all time | at high | +7354.5% | at high | +8627.6% |
Novo Nordisk A/S Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.22 B(+13.2%) |
| June 2024 | - | $16.10 B(+12.4%) |
| Mar 2024 | - | $14.33 B(-8.0%) |
| Dec 2023 | $15.57 B(+34.2%) | $15.57 B(+19.8%) |
| Sept 2023 | - | $12.99 B(+1.0%) |
| June 2023 | - | $12.86 B(+14.0%) |
| Mar 2023 | - | $11.28 B(-2.7%) |
| Dec 2022 | $11.60 B(+5.8%) | $11.60 B(+19.1%) |
| Sept 2022 | - | $9.74 B(-5.2%) |
| June 2022 | - | $10.27 B(+2.8%) |
| Mar 2022 | - | $10.00 B(-8.8%) |
| Dec 2021 | $10.96 B(+4.0%) | $10.96 B(+3.5%) |
| Sept 2021 | - | $10.60 B(-1.4%) |
| June 2021 | - | $10.75 B(+13.1%) |
| Mar 2021 | - | $9.50 B(-9.8%) |
| Dec 2020 | $10.54 B(+21.6%) | $10.54 B(+11.7%) |
| Sept 2020 | - | $9.44 B(+4.2%) |
| June 2020 | - | $9.05 B(+11.8%) |
| Mar 2020 | - | $8.10 B(-6.5%) |
| Dec 2019 | $8.67 B(+5.9%) | $8.67 B(+10.1%) |
| Sept 2019 | - | $7.87 B(-3.5%) |
| June 2019 | - | $8.16 B(+11.8%) |
| Mar 2019 | - | $7.30 B(-10.8%) |
| Dec 2018 | $8.18 B(+3.7%) | $8.18 B(+7.3%) |
| Sept 2018 | - | $7.62 B(-3.0%) |
| June 2018 | - | $7.86 B(+8.9%) |
| Mar 2018 | - | $7.22 B(-8.6%) |
| Dec 2017 | $7.89 B(+20.4%) | $7.89 B(+10.2%) |
| Sept 2017 | - | $7.16 B(-0.9%) |
| June 2017 | - | $7.23 B(+23.6%) |
| Mar 2017 | - | $5.85 B(-10.8%) |
| Dec 2016 | $6.56 B(-4.4%) | $6.56 B(+6.1%) |
| Sept 2016 | - | $6.18 B(-2.8%) |
| June 2016 | - | $6.36 B(+15.9%) |
| Mar 2016 | - | $5.48 B(-20.0%) |
| Dec 2015 | $6.86 B(+1.8%) | $6.86 B(+6.2%) |
| Sept 2015 | - | $6.46 B(+9.1%) |
| June 2015 | - | $5.92 B(+17.3%) |
| Mar 2015 | - | $5.04 B(-25.2%) |
| Dec 2014 | $6.74 B(-11.5%) | $6.74 B(+2.0%) |
| Sept 2014 | - | $6.60 B(-0.0%) |
| June 2014 | - | $6.61 B(+10.8%) |
| Mar 2014 | - | $5.96 B(-21.7%) |
| Dec 2013 | $7.61 B(+10.1%) | $7.61 B(+11.3%) |
| Sept 2013 | - | $6.84 B(+14.7%) |
| June 2013 | - | $5.96 B(+6.7%) |
| Mar 2013 | - | $5.59 B(-19.2%) |
| Dec 2012 | $6.91 B(+6.9%) | $6.91 B(+15.4%) |
| Sept 2012 | - | $5.99 B(+16.1%) |
| June 2012 | - | $5.16 B(-7.8%) |
| Mar 2012 | - | $5.60 B(-13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $6.47 B(+0.4%) | $6.47 B(+1.7%) |
| Sept 2011 | - | $6.36 B(-7.5%) |
| June 2011 | - | $6.88 B(+9.2%) |
| Mar 2011 | - | $6.30 B(-2.2%) |
| Dec 2010 | $6.44 B(-2.8%) | $6.44 B(+4.6%) |
| Sept 2010 | - | $6.16 B(+13.5%) |
| June 2010 | - | $5.43 B(-7.5%) |
| Mar 2010 | - | $5.86 B(-11.5%) |
| Dec 2009 | $6.62 B(+5.3%) | $6.62 B(+0.3%) |
| Sept 2009 | - | $6.60 B(+5.0%) |
| June 2009 | - | $6.29 B(+11.6%) |
| Mar 2009 | - | $5.63 B(-10.4%) |
| Dec 2008 | $6.29 B(+4.8%) | $6.29 B(+4.3%) |
| Sept 2008 | - | $6.03 B(-8.4%) |
| June 2008 | - | $6.58 B(+5.7%) |
| Mar 2008 | - | $6.23 B(+3.7%) |
| Dec 2007 | $6.00 B(+17.8%) | $6.00 B(-1.1%) |
| Sept 2007 | - | $6.07 B(+3.9%) |
| June 2007 | - | $5.84 B(+14.6%) |
| Mar 2007 | - | $5.10 B(-0.0%) |
| Dec 2006 | $5.10 B(+19.3%) | $5.10 B(+11.0%) |
| Sept 2006 | - | $4.59 B(-2.7%) |
| June 2006 | - | $4.72 B(+12.0%) |
| Mar 2006 | - | $4.21 B(-1.4%) |
| Dec 2005 | $4.27 B(+2.8%) | $4.27 B(+2.3%) |
| Sept 2005 | - | $4.18 B(+2.7%) |
| June 2005 | - | $4.07 B(-5.8%) |
| Mar 2005 | - | $4.32 B(+3.9%) |
| Dec 2004 | $4.16 B(+16.2%) | $4.16 B(+12.3%) |
| Sept 2004 | - | $3.70 B(+4.8%) |
| June 2004 | - | $3.53 B(+4.1%) |
| Mar 2004 | - | $3.39 B(-5.2%) |
| Dec 2003 | $3.58 B(+33.2%) | $3.58 B(+33.2%) |
| Dec 2002 | $2.69 B(+38.1%) | $2.69 B(+38.1%) |
| Dec 2001 | $1.95 B(+26.3%) | $1.95 B(+26.3%) |
| Dec 2000 | $1.54 B(-2.4%) | $1.54 B(-2.4%) |
| Dec 1999 | $1.58 B(-30.3%) | $1.58 B(-30.3%) |
| Dec 1998 | $2.26 B(+5.8%) | $2.26 B(+5.8%) |
| Dec 1997 | $2.14 B(+0.9%) | $2.14 B(+0.9%) |
| Dec 1996 | $2.12 B(+6.9%) | $2.12 B(+6.9%) |
| Dec 1995 | $1.98 B(+24.0%) | $1.98 B(+24.0%) |
| Dec 1994 | $1.60 B(+26.8%) | $1.60 B(+26.8%) |
| Dec 1993 | $1.26 B(+10.2%) | $1.26 B(+10.2%) |
| Dec 1992 | $1.15 B(+10.5%) | $1.15 B(+10.5%) |
| Dec 1991 | $1.04 B(+23.9%) | $1.04 B(+23.9%) |
| Dec 1990 | $836.53 M(+36.4%) | $836.53 M(+36.4%) |
| Dec 1989 | $613.38 M(+22.0%) | $613.38 M(+22.0%) |
| Dec 1988 | $502.64 M(-1.5%) | $502.64 M(-1.5%) |
| Dec 1987 | $510.48 M(+30.1%) | $510.48 M(+30.1%) |
| Dec 1986 | $392.49 M(+22.7%) | $392.49 M(+22.7%) |
| Dec 1985 | $319.90 M(+53.2%) | $319.90 M(+53.2%) |
| Dec 1984 | $208.81 M | $208.81 M |
FAQ
- What is Novo Nordisk A/S annual retained earnings?
- What is the all time high annual retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual retained earnings year-on-year change?
- What is Novo Nordisk A/S quarterly retained earnings?
- What is the all time high quarterly retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
What is Novo Nordisk A/S annual retained earnings?
The current annual retained earnings of NVO is $15.57 B
What is the all time high annual retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual retained earnings is $15.57 B
What is Novo Nordisk A/S annual retained earnings year-on-year change?
Over the past year, NVO annual retained earnings has changed by +$3.97 B (+34.20%)
What is Novo Nordisk A/S quarterly retained earnings?
The current quarterly retained earnings of NVO is $18.22 B
What is the all time high quarterly retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly retained earnings is $18.22 B
What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
Over the past year, NVO quarterly retained earnings has changed by +$5.23 B (+40.27%)